Trial Profile
Inhibitory effects of tocilizumab on serum oxidative stress in patients with rheumatoid arthritis -comaparison with other biologic agents-
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 14 Aug 2015 New trial record